文献速递胃肠外科围术期管理与 ERAS

袖状胃切除联合转流术治疗轻度肥胖883例的早期有效性与安全性

Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity: early effectiveness and safety outcomes.
PubMed 文献 · Surg Endosc · 2021-10-20

单中心回顾性分析883例接受袖状胃切除联合转流术(SG+TB)的轻度肥胖患者,术后12个月体重和代谢指标显著改善,HbA1C正常化率达83.3%,总体并发症率10.2%,无死亡。

要点

  • SG+TB在轻度肥胖患者中12个月平均BMI降至27.2 kg/m²,总体重丢失19.8%。
  • HbA1C正常化率83.3%,高脂血症、高血压和高甘油三酯血症显著减少。
  • 总体并发症率10.2%,无死亡,营养指标异常比例显著降低。

核心结论

  • SG+TB在较低BMI患者中可实现显著减重、合并症改善和营养稳定,主要并发症少且无死亡。

研究设计与样本

  • 单中心回顾性分析前瞻性收集的数据,883例SG+TB患者随访12个月。
  • 平均年龄51.8岁,平均BMI 34.1±5.0 kg/m²,手术时间124±25.4分钟,住院4.0±2.5天。

主要发现

  • 重复测量方差分析显示体重和代谢参数在术后1、3、6、9、12个月显著下降(p<0.005)。
  • 646例有12个月完整体重数据的患者平均BMI降至27.2±3.4 kg/m²(p<0.001),总体重丢失19.8±6.0%。
  • HbA1C正常化率83.3%,高脂血症、高血压和高甘油三酯血症显著减少(p<0.001)。
  • 营养参考范围异常的患者比例显著降低,总体并发症率10.2%,无死亡。

临床怎么用

  • SG+TB可作为轻度肥胖患者的一种减重代谢手术选择,需关注12个月内的体重和代谢改善。
  • 术后应监测营养指标,该术式显示营养稳定性较好。

局限性

  • 单中心回顾性研究,12个月随访率73.2%。
  • 摘要中结论部分提及833例较低BMI患者,与结果部分883例不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: At least 25 metabolic/bariatric procedures have been proposed globally, 5 formally endorsed. A newer procedure, sleeve gastrectomy with transit bipartition (SG + TB), appears to markedly reduce weight and improve metabolic syndrome while being relatively simple technically and protective of long-term nutritional stability. We aimed to investigate SG + TB effectiveness and safety. METHODS: In a single-center retrospective analysis of prospectively collected data, SG + TB patients were followed through 12 months. Primary outcomes were changes in weight [body mass index (BMI), total weight loss (TWL)], metabolic parameters [HbA1C, LDL cholesterol, triglycerides (TG), hypertension], and nutritional status. Repeated-measures analysis of variance (ANOVA) was used to assess changes in weight and metabolic parameters at 1, 3, 6, 9, and 12 months after surgery. RESULTS: Between 2015 and 2019, 883 patients (mean age 51.8 yrs, BMI 34.1 ± 5.0 kg/m2) underwent SG + TB. Mean operative time was 124 ± 25.4 min; hospitalization, 4.0 ± 2.5 days. ANOVA indicated significant reductions in weight and metabolic parameters (p < 0.005). In 646 patients with complete weight data at 12 months, mean BMI was reduced to 27.2 ± 3.4 kg/m2 (p < 0.001), TWL 19.8 ± 6.0%. HbA1C was normalized in 83.3% of SG + TB patients; hyperlipidemia, hypertension, and hypertriglyceridemia were significantly reduced (p < 0.001). Also, there was a significant reduction in the proportion of patients outside normal nutritional reference ranges. The overall complication rate was 10.2%. There was no mortality. CONCLUSION: In a series of 833 lower-BMI patients who underwent SG + TB and were followed through 12 months (73.2% follow-up), significant weight loss, comorbidity reduction, and nutritional stability were attained with few major complications and no mortality.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Al M, Taskin HE. Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity: early effectiveness and safety outcomes. Surg Endosc. 2021. PMID: 34671822. doi:10.1007/s00464-021-08769-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。